RainDance Adds Two Members to Board

Billerica, Mass.-based RainDance Technologies Inc., a genomics tools company making tools for the analysis of complex genetic diseases, has added Martin M. Coyne II and Glenn P. Muir to its board of directors.

Coyne currently serves as a director of Akamai Technologies, a cloud services provider, a role he has held since 2001. Before his retirement from Eastman Kodak in July 2003, he served in a variety of senior management positions including president of health imaging, president of the commercial business group and most recently, executive vice president of Eastman Kodak and group executive of the photography group. Coyne also serves as chairman of the board of RockTech, a privately held software-as-a-service business. He is president and CEO of the New Jersey Chapter of the National Association of Corporate Directors. In Oct. 2011, he was named to the Directorship 100 list of most influential directors. In the past, he served as a director of BioClinica, OpenPages, Avecia Group Plc, director and chairman of Welch Allyn and as a member of the board of the Advanced Medical Technology Association. He is also the chairman and founder of the CEO Learning Network.

“At its core RainDance is a technology company providing customers and partners with the ability to extract precise genetic data,” Coyne said. “It’s an exciting time to be at the intersection of healthcare and technology and to capitalize on genomics ‘big data’ trends as well as to be at the vanguard of fluid biopsy research of cancers and other complex diseases.”

Muir has extensive experience in financial management having guided Hologic from its early days with less than $10 million in revenue to its current position as one of the largest life science companies with annual revenues of over $2 billion. He was Hologic’s chief financial officer (CFO) from 1992 to May 2014 and executive vice president since 2000 with a broad range of financial and operating responsibilities including the oversight of the company’s strategic initiatives. He was at the helm for Hologic’s initial public offering in 1990. Currently the audit committee chair at ReWalk Robotics Ltd., his board experience also includes Hologic Inc. from 2001 to 2013 and Vivid Technologies Inc. from 1996 until the company was sold to EG&G in 1999. He was one of America’s Best CFOs as surveyed by Institutional Investor in 2009. In 2011 Boston Business Journals named him CFO of the year.